Q: Is surgery for Dupuytren’s contracture safe? What kind of results can I expect after surgery? Are there any alternatives to surgery? A: Surgery is the traditional treatment for Dupuytren’s ...
Please provide your email address to receive an email when new articles are posted on . Injectable collagenase clostridium histolyticum has revolutionized treatment of Dupuytren’s contracture as the ...
Everyday Health on MSN
How Is Dupuytren’s Contracture Treated?
Dupuytren’s contracture is a condition that causes tissue beneath the skin of your palm (fascia) to thicken and form tough ...
Dupuytren’s contracture can worsen over time if not treated, leading to fingers bending permanently toward the palm and potentially requiring surgery to regain function. The condition can ...
Compared with limited fasciectomy for Dupuytren contracture, injections of the enzyme collagenase are less costly but also less effective at straightening fingers. Nonetheless, patients may prefer the ...
Please provide your email address to receive an email when new articles are posted on . Injectable collagenase clostridium histolyticum has revolutionized treatment for Dupuytren’s contracture. In ...
Dupuytren contracture is a disorder that can cause the fingers to curl in, primarily the ring and small fingers. It's a genetic condition mostly affecting men over 60 of Northern European descent.
Add Yahoo as a preferred source to see more of our stories on Google. This is the first part of a three-part interview from Broncos Wire's Brandon Walker with Pro Football Hall of Fame quarterback ...
About Dupuytren's ContractureDC is a lifelong condition that may get worse over time. It's caused by a buildup of collagen in the hand, which forms a rope-like cord that pulls fingers toward the palm ...
DUBLIN, Jan. 13, 2026 /PRNewswire/ -- Keenova Therapeutics plc announced today that a new presentation related to Dupuytren's contracture (DC) and XIAFLEX ® (collagenase clostridium histolyticum, or ...
DUBLIN, Jan. 19, 2024 /PRNewswire/ -- Endo International plc (OTC: ENDPQ) announced today that two new presentations related to Dupuytren's contracture and XIAFLEX ® (collagenase clostridium ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results